Remote Patient Monitoring in India: A Deep Patent Base with Thin Startup Activity

What it is

Remote patient monitoring (RPM) uses digital devices—blood pressure cuffs, glucose meters, wearables—to track a patient's health outside clinics. Data flows to providers via cellular or Wi-Fi, enabling continuous oversight of chronic conditions like diabetes, heart disease, and asthma.

The technology spans simple self-testing kits to always-on wearables that stream vitals directly into electronic health records. In India, where non-communicable diseases are surging and specialist access is uneven, RPM can bridge the urban-rural gap.

The value chain

• Upstream: Device & sensor manufacturing—blood pressure monitors, glucose meters, smart inhalers. Margins are thin; defensibility comes from regulatory approvals and distribution (global player: Philips).
• Midstream: Connectivity & data transmission—cellular, Bluetooth, Wi-Fi modules that securely relay data. Value lies in reliability and low-power design.
• Midstream: Software & cloud platforms—aggregation, AI-driven analytics, and EHR integration. This is where margins and defensibility concentrate; platforms that turn raw data into clinical insights command premium pricing (HealthSnap, Oracle Health, GYANT).
• Downstream: Healthcare providers—hospitals, clinics, home health agencies that deploy RPM to manage patient panels and intervene proactively.
• End users: Patients with chronic or post-acute conditions, increasingly comfortable with at-home monitoring.

Where it's heading

• AI and machine learning are being baked into RPM platforms to predict exacerbations and automate triage, moving from reactive to proactive care (LinkedIn article).
• Wearable sensors are becoming smaller, non-invasive, and capable of tracking multiple vitals simultaneously, expanding use cases beyond chronic disease.
• Virtual clinical trials are gaining traction, using RPM to collect real-world data remotely, reducing costs and patient burden (Oracle).
• Regulatory tailwinds: the US is pushing for permanent telehealth rules, and India introduced Telemedicine Practice Guidelines in 2023, standardizing virtual care (Ken Research).
• McKinsey estimates up to $250 billion of annual US healthcare spending could be virtualized, signaling the scale of the shift (HealthSnap blog).
• In India, the telemedicine and virtual hospitals market hit INR 205 billion, driven by rural demand and digital health adoption (Ken Research).

The opportunity in India

India’s RPM patent base is deep—248 patents mapped in our dataset—with steady filing momentum. Yet only 15 companies in our data explicitly reference RPM in their profiles, and just a handful of startups have built commercial products. The 74 patent-holding startups include many individual inventors, suggesting a rich pool of early-stage innovation waiting to be productized.

Funding for RPM-specific ventures is not separately tracked, but the broader health-tech sector has attracted $2.6 billion across 973 companies. RPM remains a white space: no Indian startup has raised a large round specifically for remote monitoring platforms. The combination of a large chronic disease burden, government telehealth support, and a thin commercial field creates a wide opening for entrepreneurs who can package the existing patent IP into scalable, reimbursable services.

India signal: patents, startups, capital

Our data maps 248 patents to remote patient monitoring, with steady momentum. Patent-holding startups number 74, though many are individual inventors or incubators (e.g., Chitkara Innovation Incubator Foundation). In contrast, only 15 deep-tech companies in our dataset mention RPM in their profiles—firms like Cognota Healthcare, Cardiac Design Labs, and NuoVital.

The health-life-sciences sector has seen $2.6 billion in total funding across 973 companies, with a median raise of $1.0 million. Notable funded players in the broader sector include Enveda ($517M), Qure.ai ($130M), and SigTuple ($54.7M), but none are pure-play RPM companies. This gap between patent activity and startup capital signals an under-commercialized opportunity.

In our data

Sources

• Benefits and Challenges of Remote Patient Monitoring as Perceived by ... ↗
• Introduction to telehealth and remote patient monitoring ↗
• What Is Remote Patient Monitoring (RPM)? ↗
• 26 Leading Remote Patient Monitoring (RPM) Companies ... ↗
• 12 Remote Patient Monitoring Companies You Should ... ↗
• Who are the Top Companies in the Digital Patient ... ↗
• Remote Patient Monitoring System Market (2026 - 2033) ↗
• Remote Patient Monitoring Devices Market Size, Analysis ... ↗